Search

everythinglearnresearchcommunity

for

Search:↓

High levels of androgens during early development may cause PCOS-like symptoms.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Need better hair loss treatments beyond minoxidil, finasteride, and transplants.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.